Ablevia
Pre-clinicalAblevia is a research and development company that develops therapeutics for selective antibody removal. Its proprietary platform technology enables the development of compounds targeting undesired antibodies, autoantibodies, harmful antibodies in transplant rejection or anti-drug antibodies, neutralizing antibodies.
Founded
2018
Focus
Small Molecules
About
Ablevia is a research and development company that develops therapeutics for selective antibody removal. Its proprietary platform technology enables the development of compounds targeting undesired antibodies, autoantibodies, harmful antibodies in transplant rejection or anti-drug antibodies, neutralizing antibodies.
Company Info
TypePrivate
Founded2018
LocationVienna, Austria
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
AlgOss Biotechnologies
Pre-clinical · Graz
Angios Biotech
Pre-clinical ·
F4 Pharma
Pre-clinical · Vienna
aTENSION.life
Pre-clinical · Vienna
Austrianni
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile